Sorafenib for the treatment of advanced hepatocellular carcinoma

Por M Connock, J Round, S Bayliss, S Tubeuf, W Greenheld, D Moore
Publicado em 2010-05-01

Infliximab for the treatment of acute exacerbations of ulcerative colitis

Por S Bryan, L Andronis, C Hyde, M Connock, A Fry-Smith, D Wang
Publicado em 2010-05-01

Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia

Por J Dretzke, P Barton, B Kaambwa, M Connock, O Uthman, S Bayliss, C Meads
Publicado em 2010-10-01

A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compres...

Por P Sutcliffe, M Connock, D Shyangdan, R Court, N-B Kandala, A Clarke
Publicado em 2013-09-01

Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis

Por M Connock, S Tubeuf, K Malottki, A Uthman, J Round, S Bayliss, C Meads, D Moore
Publicado em 2010-10-01

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia

Por R Edlin, M Connock, S Tubeuf, J Round, A Fry-Smith, C Hyde, W Greenheld
Publicado em 2010-05-01

Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review

Por DA Lane, S Raichand, D Moore, M Connock, A Fry-Smith, DA Fitzmaurice, on behalf of the Steering Committee
Publicado em 2013-07-01

Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews

Por P Sutcliffe, M Connock, T Gurung, K Freeman, S Johnson, N-B Kandala, A Grove, B Gurung, S Morrow, A Clarke
Publicado em 2013-09-01

Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumours

Por J Dretzke, J Round, M Connock, S Tubeuf, M Pennant, A Fry-Smith, C Hulme, C McCabe, C Meads
Publicado em 2010-10-01

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn’s disease

Por J Dretzke, R Edlin, J Round, M Connock, C Hulme, J Czeczot, A Fry-Smith, C McCabe, C Meads
Publicado em 2011-02-01

Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults...

Por P Sutcliffe, M Connock, R Pulikottil-Jacob, N-B Kandala, G Suri, T Gurung, A Grove, D Shyangdan, S Briscoe, H Maheswaran, A Clarke
Publicado em 2013-11-01

Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review a...

Por K Malottki, P Barton, A Tsourapas, AO Uthman, Z Liu, K Routh, M Connock, P Jobanputra, D Moore, A Fry-Smith, Y-F Chen
Publicado em 2011-03-01